FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944549872> ?p ?o ?g. }

• W2944549872 endingPage "204062231984788" @default.
• W2944549872 startingPage "204062231984788" @default.
• W2944549872 abstract "The objective of this study was to investigate the effectiveness and safety of interferon (IFN) α2a as an add-on treatment for refractory Behçet's uveitis (BU).In this retrospective cohort study, 30 refractory BU patients who received IFNα2a treatment in Peking Union Medical College Hospital between February 2015 and June 2018 were consecutively included. IFNα2a was used mainly as an add-on treatment for BU patients who underwent relapse under corticosteroids and conventional immunosuppressive agents. The primary outcome was treatment success rate before and after initiation of IFNα2a. Changes in ocular relapse rates, disease activity, corticosteroid- and immunosuppressant-sparing effects, as well as side effects were secondary outcomes.A total of 30 patients (27 males and 3 females) with a mean age of 30.5 ± 8.7 years were included. Twenty-one patients (70%) were treated with at least 2 immunosuppressive agents before the initiation of IFNα2a. Treatment success was achieved in 26 patients (86.7%), and the median uveitis relapse rate decreased from 7.3 (range 2-12) to 0 (range 0-6) per patient-year (p = 0.000002) during a mean follow-up of 21.7 ± 7.5 months, corticosteroids were lowered in 25 cases (83.3%) and completely withdrawn in four (13.3%). In addition, immunosuppressive agents were reduced in number and dosage in 22 (73.3%) and 29 patients (96.7%), respectively, and were completely withdrawn in 12 cases (40%). No severe adverse events were observed and serum autoantibodies remained negative during the treatment of IFNα2a.IFNα2a is effective and relatively safe in refractory BU, with significant steroid- and immunosuppressant-sparing effects." @default.
• W2944549872 created "2019-05-16" @default.
• W2944549872 creator A5008382096 @default.
• W2944549872 creator A5009256113 @default.
• W2944549872 creator A5012278873 @default.
• W2944549872 creator A5027968892 @default.
• W2944549872 creator A5047202858 @default.
• W2944549872 creator A5048371164 @default.
• W2944549872 creator A5056582438 @default.
• W2944549872 creator A5073523669 @default.
• W2944549872 creator A5079767292 @default.
• W2944549872 date "2019-01-01" @default.
• W2944549872 modified "2023-09-30" @default.
• W2944549872 title "Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis" @default.
• W2944549872 cites W152687799 @default.
• W2944549872 cites W1964372332 @default.
• W2944549872 cites W1972240373 @default.
• W2944549872 cites W1991789078 @default.
• W2944549872 cites W1999498885 @default.
• W2944549872 cites W2000471297 @default.
• W2944549872 cites W2004943888 @default.
• W2944549872 cites W2017447237 @default.
• W2944549872 cites W2021626719 @default.
• W2944549872 cites W2032537032 @default.
• W2944549872 cites W2036527794 @default.
• W2944549872 cites W2038535814 @default.
• W2944549872 cites W2040235283 @default.
• W2944549872 cites W2044912319 @default.
• W2944549872 cites W2045850959 @default.
• W2944549872 cites W2052004574 @default.
• W2944549872 cites W2056756250 @default.
• W2944549872 cites W2064729318 @default.
• W2944549872 cites W2067499731 @default.
• W2944549872 cites W2068397593 @default.
• W2944549872 cites W2070588678 @default.
• W2944549872 cites W2074892708 @default.
• W2944549872 cites W2080970660 @default.
• W2944549872 cites W2085737748 @default.
• W2944549872 cites W2099200878 @default.
• W2944549872 cites W2099726337 @default.
• W2944549872 cites W2102997845 @default.
• W2944549872 cites W2139499737 @default.
• W2944549872 cites W2139925607 @default.
• W2944549872 cites W2170726975 @default.
• W2944549872 cites W2298863506 @default.
• W2944549872 cites W2424169461 @default.
• W2944549872 cites W2511140591 @default.
• W2944549872 cites W2525450878 @default.
• W2944549872 cites W2550856303 @default.
• W2944549872 cites W2765095237 @default.
• W2944549872 cites W4300492363 @default.
• W2944549872 cites W652596912 @default.
• W2944549872 doi "https://doi.org/10.1177/2040622319847881" @default.
• W2944549872 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6505232" @default.
• W2944549872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31105923" @default.
• W2944549872 hasPublicationYear "2019" @default.
• W2944549872 type Work @default.
• W2944549872 sameAs 2944549872 @default.
• W2944549872 citedByCount "12" @default.
• W2944549872 countsByYear W29445498722019 @default.
• W2944549872 countsByYear W29445498722020 @default.
• W2944549872 countsByYear W29445498722021 @default.
• W2944549872 countsByYear W29445498722022 @default.
• W2944549872 countsByYear W29445498722023 @default.
• W2944549872 crossrefType "journal-article" @default.
• W2944549872 hasAuthorship W2944549872A5008382096 @default.
• W2944549872 hasAuthorship W2944549872A5009256113 @default.
• W2944549872 hasAuthorship W2944549872A5012278873 @default.
• W2944549872 hasAuthorship W2944549872A5027968892 @default.
• W2944549872 hasAuthorship W2944549872A5047202858 @default.
• W2944549872 hasAuthorship W2944549872A5048371164 @default.
• W2944549872 hasAuthorship W2944549872A5056582438 @default.
• W2944549872 hasAuthorship W2944549872A5073523669 @default.
• W2944549872 hasAuthorship W2944549872A5079767292 @default.
• W2944549872 hasBestOaLocation W29445498721 @default.
• W2944549872 hasConcept C121332964 @default.
• W2944549872 hasConcept C126322002 @default.
• W2944549872 hasConcept C141071460 @default.
• W2944549872 hasConcept C142424586 @default.
• W2944549872 hasConcept C167135981 @default.
• W2944549872 hasConcept C197934379 @default.
• W2944549872 hasConcept C203014093 @default.
• W2944549872 hasConcept C2776194053 @default.
• W2944549872 hasConcept C2779134260 @default.
• W2944549872 hasConcept C2781428731 @default.
• W2944549872 hasConcept C71924100 @default.
• W2944549872 hasConcept C72563966 @default.
• W2944549872 hasConcept C87355193 @default.
• W2944549872 hasConcept C90924648 @default.
• W2944549872 hasConceptScore W2944549872C121332964 @default.
• W2944549872 hasConceptScore W2944549872C126322002 @default.
• W2944549872 hasConceptScore W2944549872C141071460 @default.
• W2944549872 hasConceptScore W2944549872C142424586 @default.
• W2944549872 hasConceptScore W2944549872C167135981 @default.
• W2944549872 hasConceptScore W2944549872C197934379 @default.
• W2944549872 hasConceptScore W2944549872C203014093 @default.
• W2944549872 hasConceptScore W2944549872C2776194053 @default.
• W2944549872 hasConceptScore W2944549872C2779134260 @default.

• next